Kelvin K. Tsai

Taipei, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids.

Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoids.

Journal: European journal of medicinal chemistry
Published: July 12, 2025

NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.

NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.

Journal: Nature communications
Published: July 07, 2025

Chemotherapy resistance of urinary bladder cancer mediated by a Notch and Wnt co-regulatory module of stemness.

Chemotherapy resistance of urinary bladder cancer mediated by a Notch and Wnt co-regulatory module of stemness.

Journal: Stem cells (Dayton, Ohio)
Published: June 09, 2025

NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.

NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025

Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

Journal: Molecular cancer research : MCR
Published: January 16, 2025

The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability.

The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability.

Journal: Cancer metastasis reviews
Published: November 18, 2024

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Journal: Journal of medicinal chemistry
Published: September 25, 2024

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids.

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids.

Journal: European journal of medicinal chemistry
Published: May 23, 2024

Correction: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.

Correction: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.

Journal: The Journal of experimental medicine
Published: June 20, 2023

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

Journal: Molecular oncology
Published: April 01, 2023

Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers.

Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers.

Journal: Cancer research
Published: January 18, 2023

ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression.

ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression.

Journal: Cancer research
Published: August 29, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026